Sumitomo Dainippon (Germany) Profile

13.19
EUR 0.45  3.53%
100%
100%

Sumitomo Dainippon Summary

Sumitomo Dainippon Pharma Co Ltd (DPM) is traded on Frankfurt Stock Exchange in Germany. It is located in 6-8 Doshomachi 2-chome and employs 6,492 people. The company currently falls under 'Mid-Cap' category with current market capitalization of 5.23 B. Sumitomo Dainippon Pharma Co Ltd has 397.3 M outstanding shares. DAINIP S'TOMO PHA has accumulated about 1.29 B in cash with 476.38 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.24.
Check Sumitomo Dainippon Probability Of Bankruptcy

Sumitomo Dainippon P Risk Profiles

Key Fundamentals

Sumitomo Dainippon Against Markets

Current Ratings

Sumitomo Dainippon 30 Days Performance Scores
Risk Adjusted
Performance Score (0 to 100)
10 
Chance of
Financial Distress (0 to 100%)
< 30% 
Equity ratings for Sumitomo Dainippon Pharma Co Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Sumitomo Dainippon Pharma Co., Ltd. manufactures and sells pharmaceuticals, food ingredients, food additives, veterinary medicines, diagnostics, and others. Sumitomo Dainippon Pharma Co., Ltd. is a subsidiary of Sumitomo Chemical Company, Limited. Sumitomo Dainippon is traded on Frankfurt Stock Exchange in Germany. more
NameSumitomo Dainippon Pharma Co Ltd
CEOJonathan GoodmanAll Leadership
Macroaxis Advice
InstrumentGermany Stock Stocks Directory
Business Address6-8 Doshomachi 2-chome
Foreign Associate  USA
ExchangeFrankfurt Stock Exchange
BenchmarkDOW
Websitewww.ds-pharma.com
Contact Number81 6 6203 5321
CurrencyEUR - Euro

Directors

Sumitomo Dainippon Corporate Directors
Peter Nixon Independent Director
Peter Gillin Lead Independent Director
MarieAnne Tawil Director, MBA

Opportunities

Explore Investment Opportunities
Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked.
Explore Investing Ideas  

Directors

Sumitomo Dainippon Corporate Directors
Peter Nixon Independent Director
Peter Gillin Lead Independent Director
MarieAnne Tawil Director, MBA